ISRG Intuitive Surgical (NASDAQ) pre-market $488.15 09 Feb 2026: AI stocks outlook

Pre-market on 09 Feb 2026 Intuitive Surgical, Inc. (ISRG) trades at $488.15 on the NASDAQ in the United States, up 2.48% from the prior close. ISRG stock shows heavy trading with 2,518,458.00 shares changing hands so far, and a market cap near 173.36 billion USD. The company reports EPS 7.85 and a PE of 62.18, reflecting growth expectations in surgical robotics and digital tools. For AI stocks investors, ISRG’s expanding digital platform and data services matter as much as hardware sales, so we focus on valuation, momentum, and model-driven forecasts below.

ISRG stock snapshot and recent moves

ISRG stock opened pre-market at $482.17 and is trading near $488.15 on 09 Feb 2026. The intraday range is $480.07 to $491.65, and average volume sits at 1,905,611.00, signaling above-average activity today.

Year-to-date performance is down 13.14%, and the 52-week range is $425.00 to $609.08. Recent news flow includes institutional filings and short-interest updates that likely influenced today’s 2.48% move. For the latest filings see MarketBeat coverage.

ISRG stock fundamentals and valuation

Intuitive Surgical, Inc. (ISRG) posts strong margins with a net margin near 28.38% and return on equity about 16.72%, supporting its premium valuation. Key metrics show revenue per share 28.36, free cash flow per share 6.40, and cash per share 13.83, which underpin balance-sheet strength.

The market prices that strength at a high multiple: trailing PE near 62.18, price-to-sales around 17.21, and price-to-book roughly 10.23. These ratios place ISRG above healthcare capital equipment peers and matter for AI stocks investors weighing growth versus valuation.

ISRG stock technicals and momentum

Technicals give a mixed picture for ISRG stock. The RSI sits at 65.69, edging toward overbought, while MACD shows a positive but small histogram at 0.11, indicating modest bullish momentum. The 50-day average is 552.16 and the 200-day average is 516.38, both above today’s price, highlighting short-term downside pressure.

Volume indicators show on-balance volume near 24,818,529.00, and ATR at 11.47 indicates multi-dollar intraday swings. Momentum oscillators and a positive MACD cross argue for tactical strength, but prices must clear moving averages to confirm a durable uptrend.

ISRG stock analyst consensus and price targets

Wall Street consensus skews positive with a Moderate Buy rating and an average price target near $617.23. Several firms raised targets into late 2025 and early 2026, including high-range estimates above $650.00, reflecting confidence in recurring instrument revenue and services. Analysts cite accelerating procedures and software monetization as drivers.

This consensus matters for ISRG stock because target upgrades and earnings beats tend to move sentiment quickly, as seen after the January quarter result where ISRG beat EPS expectations with $2.53 per share and revenue of $2.87 billion.

ISRG stock risks and AI-related opportunities

Risk factors for ISRG stock include valuation sensitivity, procedure volume volatility, and competitive pressure as rivals target robotic and diagnostic markets. High multiples mean disappointed growth could trigger sharp downside.

Opportunities tie to AI and software. Intuitive’s digital platform and data services can add recurring revenue, improve instrument utilization, and enable advanced automation. For AI stocks investors, ISRG’s clinical data and procedural scale are strategic assets if translated to software monetization.

Meyka AI rates ISRG stock with a proprietary grade

Meyka AI rates ISRG with a score out of 100: Score 78.55 | Grade B+ | Suggestion: BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

This grade is informational. These grades are not guaranteed and we are not financial advisors. Review your risk profile before acting. For ongoing, AI-powered market analysis see the Meyka ISRG page: Meyka AI ISRG page.

Final Thoughts

Key takeaways for ISRG stock: Intuitive Surgical trades at $488.15 pre-market on 09 Feb 2026, with a premium valuation at PE 62.18 and a market cap near 173.36 billion USD. Short-term technicals show momentum but price sits below the 50-day average near 552.16, which is a resistance level to watch. Meyka AI’s forecast model projects a 1-year price of $604.32, implying an upside of 23.79% versus today’s $488.15. The model also shows a nearer-term quarterly projection of $514.64 (up 5.43%) and a monthly projection of $424.33 (down 13.07%), underlining scenario risk. Forecasts are model-based projections and not guarantees. For AI stocks investors, ISRG’s combination of hardware, software and clinical data gives a durable growth thesis, but the stock’s premium multiples require consistent execution to justify further gains.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.